BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11408715)

  • 1. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
    Tsatalas C; Margaritis D; Kaloutsi V; Martinis G; Kotsianidis I; Bourikas G
    Acta Haematol; 2001; 105(2):106-8. PubMed ID: 11408715
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
    Tsatalas C; Margaritis D; Pantelidou D; Spanudakis E; Kaloutsi V; Bourikas G
    Acta Haematol; 2003; 109(2):110. PubMed ID: 12624498
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320.
    Townsend W; Johnson RJ; Pottinger BT; Counsell N; Smith P; Chadwick H; Evans K; Wickham C; Rudin CE;
    Leuk Lymphoma; 2016 Sep; 57(9):2232-4. PubMed ID: 27001186
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment with fludarabine in two cases of angioimmunoblastic lymphadenopathy with dysproteinemia.
    Hast R; Jacobsson B; Petrescu A; Hjalmar V
    Leuk Lymphoma; 1999 Aug; 34(5-6):597-601. PubMed ID: 10492085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine.
    Ong ST; Koeppen H; Larson RA; Olopade OI
    Blood; 1996 Sep; 88(6):2354-5. PubMed ID: 8822958
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunoblastic lymphadenopathy-like T cell lymphoma with high level of serum interleukin-2 and various allergic reactions].
    Tsujisaki M; Nakahara S; Kazama Y; Shimizu H; Yoshimoto M; Takahashi T; Okada Y; Sasaki S; Imai K
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Dec; 25(6):452-7. PubMed ID: 12630426
    [No Abstract]   [Full Text] [Related]  

  • 7. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
    Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851
    [No Abstract]   [Full Text] [Related]  

  • 8. CD20 expression in angioimmunoblastic T cell lymphoma.
    Foukas PG; Kefala M; Papageorgiou S; Tsirigotis P; Panayiotidis P; Korkolopoulou P; Spathis A; Dervenoulas J; Patsouris E; Karakitsos P; Panayiotides IG
    Leuk Lymphoma; 2012 Feb; 53(2):345-7. PubMed ID: 21919822
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary cerebral angioimmunoblastic T-cell lymphoma.
    Lachenal F; Berger F; Cimarelli S; Formaglio M; Ghesquières H
    J Clin Oncol; 2013 Feb; 31(5):e64-8. PubMed ID: 23295811
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone.
    Gerlando Q; Barbera V; Ammatuna E; Franco V; Florena AM; Mariani G
    Haematologica; 2000 Aug; 85(8):880-1. PubMed ID: 10942945
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.
    Shiratori S; Kosugi-Kanaya M; Shigematsu A; Kobayashi H; Yamamoto S; Kobayashi N; Iwasaki H; Mori A; Kunieda Y; Yutaka T; Kurosawa M; Kakinoki Y; Endo T; Kondo T; Hashino S; Teshima T;
    Leuk Lymphoma; 2015; 56(9):2592-7. PubMed ID: 25563559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains.
    Jaffe ES
    Ann Oncol; 1995 Sep; 6(7):631-2. PubMed ID: 8664181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of fludarabine in the treatment of angioimmunoblastic lymphoma (AIL)].
    Bourgeois E; Auxenfants E; Jouffrey C; Dubest C; Mahieu M; Rose C
    Ann Med Interne (Paris); 2000 May; 151(3):230-1. PubMed ID: 10896978
    [No Abstract]   [Full Text] [Related]  

  • 14. Angioimmunoblastic T-cell lymphoma mimicking Crohn's disease.
    Kang HY; Hwang JH; Park YS; Bang SM; Lee JS; Chung JH; Kim H
    Dig Dis Sci; 2007 Oct; 52(10):2743-7. PubMed ID: 17394065
    [No Abstract]   [Full Text] [Related]  

  • 15. Angioimmunoblastic T-Cell Lymphoma with Polyarthritis Resembling Rheumatoid Arthritis.
    Yachoui R; Farooq N; Amos JV; Shaw GR
    Clin Med Res; 2016 Dec; 14(3-4):159-162. PubMed ID: 28188140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocytoclastic vasculitis with IgA deposits in angioimmunoblastic T cell lymphoma.
    Sugaya M; Nakamura K; Asahina A; Tamaki K
    J Dermatol; 2001 Jan; 28(1):32-7. PubMed ID: 11280462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?
    van der Weyden C; Harrop S; Prince HM
    Leuk Lymphoma; 2020 Sep; 61(9):2031-2033. PubMed ID: 32729765
    [No Abstract]   [Full Text] [Related]  

  • 18. Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in
    Tobiasson M; Pandzic T; Cavelier L; Sander B; Wahlin BE
    Leuk Lymphoma; 2019 Dec; 60(13):3316-3319. PubMed ID: 31204875
    [No Abstract]   [Full Text] [Related]  

  • 19. A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis.
    De Samblanx H; Verhoef G; Zachée P; Vandenberghe P
    Ann Hematol; 2004 Jul; 83(7):455-9. PubMed ID: 15034757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual relapse of an angioimmunoblastic T cell lymphoma 11 years after initial manifestation.
    Lohneis P; Jakob C; Hummel M; Jöhrens K; Anagnostopoulos I
    Ann Hematol; 2015 Feb; 94(2):347-9. PubMed ID: 24923452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.